第五屆年度 ECD 醫學研討會，紐約州紐約市
紐約 2017 年醫學研討會合照
研討會摘要
2017 年年度 ECD 醫學研討會共有來自 8 個國家的約 65 名醫療專業人士出席。會中發表了 18 份口頭摘要以及另外 5 份海報展示。Neal Rosen 醫學博士兼哲學博士發表了受邀演講。 晚間招待會為這群知識淵博、且皆有志於深入了解 Erdheim-Chester 疾病的醫師與科學家提供了交流時間，以支持目前及未來的合作。
含研討會議程的計畫
介紹
以下新增的簡報內容，希望能幫助其他有興趣進一步瞭解 ECD 的醫師與研究人員。ECDGA 感謝醫學界為改善 ECD 患者照護所做的努力與貢獻。
| Presenter | Presentation Slides | English Video |
|---|---|---|
| Ankush Bhatia, MD | Single-agent dabrafenib for BRAFV600E-mutated histiocytosis | Not available. |
| Riccardo Biavasco, MD | BRAFV600E expression in hematopoietic progenitors leads to myeloid skewing and histiocytosis | Not available. |
| Pascale Chasseur, MD | A cytologic diagnosis of BRAFV600E Erdheim-Chester disease on pericardial fluid | Not available. |
| Marina Ferrarini, MD | 3-D culture of BRAF and KRAS-mutated Erdheim-Chester disease tissues: impact of kinase inhibitors | Not available. |
| Aaron Goodman, MD | Genomics of Erdheim Chester Disease: Implications for Precision Treatment with Targeted Therapy | Not available. |
| Gaurav Goyal, MBBS | Efficacy of Biologic Agents in the Treatment of Erdheim-Chester Disease | Not available. |
| Gaurav Goyal, MBBS | Increased prevalence of myeloid neoplasms in patients with Erdheim-Chester disease | Not available. |
| Julien Haroche, MD, PhD | BRAF V600E mutation is associated with a cardiac and neurological phenotype in Erdheim-Chester disease: results from a 165-patient cohort | Not available. |
| Filip Janku, MD, PhD | Clinical molecular profiling of archival tumor tissue and cell-free DNA from patients with Erdheim-Chester disease | Not available. |
| Augusto Vaglio, MD | Renal and ureteral involvement in Erdheim-Chester disease: analysis of a single centre cohort | Not available. |
| Neal Rosen, MD, PhD | Not available. | Not available. |
| Juvianee Estrada-Veras, MD | Adult Patients with Mixed Histiocytosis: Cases from the NIH Clinical Center | Not available. |
| Benjamin H. Durham, MD | Genomic Analysis Identifies Novel Kinase Alterations in the Histiocytic Neoplasms | Not available. |
| Domenico Corradi, MD | Pro-Collagen Type I Expression In Foamy Histiocytes From Erdheim-Chester Disease Biopsies | Not available. |
| Eli L. Diamond, MD | Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Disorders: Interim Results | Not available. |
| Disha Dalela, MBBS | The Masquerader- ECD presenting as PUO | Not available. |
| Rahul H. Dave, MD, PhD | Neurologic Involvement in Erdheim-Chester Disease | Not available. |
| S. Mojdeh Mirmomen and Moozhan Nikpanah | Abdominal and Thoracic Imaging Presentations of 61 Cases of ECD: Association with BRAFV600E Mutation | Not available. |
| Roei Mazor, MD | Comparative Analysis of Tandem PET/CT & PET/MR Studies in the Evaluation of Patients with Inflammatory Myeloid Neoplasms | Not available. |
| Eli L. Diamond, MD | IMPACT: MSKCC targeted tumor sequencing test available for ECD patients | Not available. |
| Eli L. Diamond, MD | Update Consensus Guidelines | Not available. |
| Mark Heaney, MD, PhD, Eli L. Diamond, MD, Kathleen Brewer | Closing | Not available. |
